Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 34313746.
- Also identified by DOI 10.1001/jamanetworkopen.2021.18410 and PMC identifier 8316999.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cohort study examines the risk of skeletal-related events associated with the frequency of bisphosphonate treatment in patients with multiple myeloma.
Medical subject headings
- Bone Density Conservation Agents
- Bone Diseases
- Diphosphonates
- Multiple Myeloma